Patient Characteristics and Bleeding Events in Non-Valvular Atrial Fibrillation Patients Treated with Apixaban or Vitamin K Antagonists: Real-World Study in Italy

Trial Profile

Patient Characteristics and Bleeding Events in Non-Valvular Atrial Fibrillation Patients Treated with Apixaban or Vitamin K Antagonists: Real-World Study in Italy

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2017

At a glance

  • Drugs Apixaban (Primary) ; Vitamin K antagonists
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Nov 2017 Results presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
    • 23 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top